[Use of human papilloma virus testing in primary cervical cancer screening in rural Madagascar]
- PMID: 30448093
- DOI: 10.1016/j.respe.2018.10.003
[Use of human papilloma virus testing in primary cervical cancer screening in rural Madagascar]
Abstract
Background: Testing for high-risk human papilloma virus (HR-HPV) is an effective approach to the prevention of cervical cancer. This study in the Atsinanana area of Madagascar aimed to compare the management of women screened by visual inspection after coloration with acetic acid (VIA) and the management of women screened by HPV with VIA as a triage test.
Method: During the last two screening campaigns, the first patients (between 28 and 120 women par center) were sampled using a dry swab, just before the acetic acid application, to test 14 genotypes of HR-HPV using Roche Diagnostics Cobas® Test. We compared current management practices based on primary VIA to those that would have been implemented if the clinician had followed the recommendations of the World Health Organization for HPV-based primary screening. We used a regression Poisson model with random effect and robust variance.
Results: Among the 250 screened-women, 28 (11.2%) had acidophilic lesions of the uterine cervix or suspected lesions of invasive cancer (IVA +). The HPV test was positive in 62 cases (24.8%). The HPV-based screening strategy would have reduced by 52% the number of women needing thermo-coagulation treatment: 24 women (9.6%) with primary VIA-based screening vs. 13 women (5.2%) with primary HPV-based screening; RR: 0.52 and 95%CI: 0.27-1.02. The diagnosis of severe dysplastic lesion or invasive cancer would not have changed.
Conclusion: Primary HPV-based screening is a strategy that could be useful for low-resource countries like Madagascar. It would reduce the rate of false positives and unnecessary treatments compared to the current strategy based on primary IVA. The questions of the feasibility and cost-benefit of this strategy should be further explored.
Keywords: Cancer du col utérin; Cervical cancer; Dépistage; Dépistage et traitement immédiat; Génotype à haut-risque; High-risk genotypes; Human papilloma virus; Inspection visuelle après coloration à l’acide acétique (IVA); Screening; See and treat; Visual inspection after coloration with acetic acid (VIA).
Copyright © 2018 Elsevier Masson SAS. All rights reserved.
Similar articles
-
[A study of cervical cancer screening algorithms].Zhonghua Zhong Liu Za Zhi. 2010 Jun;32(6):420-4. Zhonghua Zhong Liu Za Zhi. 2010. PMID: 20819481 Chinese.
-
[Cervical cancer screening in rural Madagascar: Feasibility, coverage and incidence].J Gynecol Obstet Hum Reprod. 2017 Apr;46(4):327-332. doi: 10.1016/j.jogoh.2017.03.003. Epub 2017 Mar 18. J Gynecol Obstet Hum Reprod. 2017. PMID: 28643659 French.
-
[Real-world research on cervical cancer screening program and effect evaluation for Chinese population].Zhonghua Zhong Liu Za Zhi. 2018 Oct 23;40(10):764-771. doi: 10.3760/cma.j.issn.0253-3766.2018.10.008. Zhonghua Zhong Liu Za Zhi. 2018. PMID: 30392341 Chinese.
-
Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.Vaccine. 2008 Aug 19;26 Suppl 10:K29-41. doi: 10.1016/j.vaccine.2008.06.019. Vaccine. 2008. PMID: 18847555 Review.
-
Screening of Cervical Cancer with Self-Collected Cervical Samples and Next-Generation Sequencing.Dis Markers. 2018 Nov 14;2018:4826547. doi: 10.1155/2018/4826547. eCollection 2018. Dis Markers. 2018. PMID: 30538783 Free PMC article. Review.
Cited by
-
Prevalence and Risk Factors of Cervical Lesion Among Married Women With Low Socioeconomic Status: A Study Based on a Cervical Cancer Screening Program.Int J Public Health. 2025 Jun 20;70:1608482. doi: 10.3389/ijph.2025.1608482. eCollection 2025. Int J Public Health. 2025. PMID: 40621116 Free PMC article.
-
Acceptability of HPV screening among HIV-infected women attending an HIV-dedicated clinic in Abidjan, Côte d'Ivoire.BMC Womens Health. 2020 Jul 28;20(1):155. doi: 10.1186/s12905-020-01021-6. BMC Womens Health. 2020. PMID: 32723350 Free PMC article.